flow trial semaglutide kidney outcomes results 2024 nejm hazard ratio 0.76 FLOW- the Visual Abstract — NephJC Treatment with sodium–glucose cotransporter 2 – Study: Semaglutide slowed progression of

A 3-Step Plan for Rapid Rehydration Now that you know the signs of dehydration GLP1 users often face, the next step is knowing how to respondgently but effectively

While we noted a more variable shift in fecal total SCFAs, acetate, propionate, butyrate, or valerate (via targeted GCMS), in the Low weight loss responders, there was no significant difference when compared to High weight loss responders (Wilcoxon rank-sum test, p 0.210

It's unclear how safe semaglutide "would be for a person of normal weight." Join 350,000+ subscribers and keep yourself informed with a selection of The Weeks most interesting, enlightening and entertaining stories - plus daily puzzles

for %WL of 4.0, a dropout rate of 10% and 1% critical significance level, 62 patients (31 per group) would provide at least 95% power to detect an estimated difference of 10%WL with a 95% CI no wider than 8.0 to 12.0

Summary of included studies regarding the adverse psychiatric outcomes associated with GLP-1-RAs)